Global Med Technologies(R), Inc. to Present at Inaugural LD MICRO Conference at the Omni Hotel in Los Angeles

Wednesday, April 23, 2008 General News J E 4
DENVER, April 22 Global Med Technologies(R),Inc. (OTC Bulletin Board: GLOB), an international e-Health, medicalinformation technology company, today announced that its founder and CEO,Michael I. Ruxin, M.D., will be presenting the Company's story at the first LDMICRO annual conference at the Omni Los Angeles hotel on Tuesday, April 29, at1:00 p.m. PDT.


"It is truly gratifying to be included among the outstanding publiclytraded companies presenting at this conference," said Dr. Ruxin. "Global MedTechnologies is on an exciting growth path and is working toward impressiveinternational expansion and leadership in its field. We welcome theopportunity to highlight the recent exciting events that have transpired aswell as the Company's direction going forward," Dr. Ruxin added.


LD MICRO is a by-invitation only newsletter firm that focuses on findingundervalued companies in the micro-cap space. Since 2002, the firm haspublished an annual list of recommended stocks as well as comprehensivereports on select companies throughout the year. For the past several years,LD MICRO has concentrated on finding, researching, and investing in companiesthat are overlooked by institutional investors. For more information on thelist of presenting companies or to register for the event, please visit or call (310) 862-4512.

About Global Med Technologies, Inc.

Global Med Technologies(R), Inc. is an international e-Health medicalinformation technology company providing information management softwareproducts and services to the healthcare industry. Its WyndgateTechnologies(R) division is a leading supplier of information managementsystems to U.S. and international blood centers and hospital transfusioncenters. Each year, Wyndgate's products and services manage more than eightmillion blood components, representing over 27% of the U.S. blood supply.Wyndgate's products are also being used in Canada, Africa, and the Caribbean.Wyndgate's software provides Vein-to-Vein(R) tracking from donor collection topatient transfusion through its Donor Doc(TM) interactive donor health historyquestionnaire, ElDorado Donor(TM) and SafeTrace(R) donor management systems,to its SafeTrace Tx(R) advanced transfusion management system. Global Med'sPeopleMed(R), Inc. subsidiary provides custom software validation, consultingand compliance solutions to hospitals and blood centers. PeopleMed's in-depthknowledge of Wyndgate's products and the blood banking industry results incost-effective validation services, which leads to more efficient softwareimplementations and upgrades for our customers.

For more information about Global Med's products and services, please call800-WYNDGATE or visit, http://www.peoplemed.comand

This news release may include statements that constitute forward-lookingstatements, usually containing the words "believe," "estimate," "project,""expects" or similar expressions. These statements are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of1995. Forward-looking statements inherently involve risks and uncertaintiesthat could cause actual results to differ materially from the forward-lookingstatements. By making these forward-looking statements, the Companyundertakes no obligation to update these statements for revisions or changesafter the date of this news release.

SOURCE Global Med Technologies, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Vocantas Inc. announces partnership with Communica...
SoloHealth Secures $1.8 Million Seed Round From In...